Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

by Chang Liu et al.

SARS-CoV-2 has undergone progressive change with variants conferring advantage rapidly becoming dominant lineages e.g. B.1.617. With apparent increased transmissibility variant B.1.617.2 has contributed to the current wave of infection ravaging the Indian subcontinent and has been designated a variant of concern in the UK. 

29th June 2021 • comment